Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers

Experimental and Molecular Medicine

Volumn 34, Issue 1, 2002, Pages 18-26

  Lee, Youn Soo ^a   Kim, Tae Eung ^a   Kim, Byung Kee ^a   Park, Yong Gyu ^a   Kim, Gyu Moon ^a   Jee, Sung Bae ^a   Ryu, Ki Sung ^a   Kim, In Kyung ^a   Kim, Jin Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

HLA class I; HLA class II; Immunohistochemical staining; Metastasis; Ovarian cancer

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; HLA ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; OVARY ADENOCARCINOMA; OVARY CANCER; ADENOCARCINOMA; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; OVARY TUMOR; PATHOLOGY;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; OVARIAN NEOPLASMS;

EID: 0037204458     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2002.3     Document Type: Article

References (35)

1. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis
2. Intraperitoneal recombinant γ-interferon in patients with recurrent ascitic ovarian carcinoma: Modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells
3. HLA and cancer: Implications for cancer immunotherapy and vaccination
4. Map of the human MHC
5. Different patterns of HLA DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast
6. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas
7. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours
8. Expression of MHC products and leukocyte differentiation antigens in gynaecological neoplasms: An immunohistological analysis of the tumor cells and infiltrating leukocytes
9. Human leukocyte antigen-DR is a differentiation antigen for human granulosa cells
10. Natural history of HLA expression during tumor development
11. HLA class I antigens in human tumors
12. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
13. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: Relation with malignancy and invasiveness
14. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
15. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma
16. MHC-based diagnostics and therapeutics
17. The use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedures
18. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms
19. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer
20. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines
21. Differential expression of HLA class I and II antigens in primary and metastatic melanomas
22. Expression of HLA-class II antigen in gastric carcinomas. Its relationship to histopathological grade, lymphocyte infiltration and five-year survival rate
23. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule
24. Cytokine regulation of expression of class I MHC antigens
25. Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas
26. MHC antigens in human melanomas
27. MHC antigens on human tumor
28. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers
29. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells
30. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues
31. Association of class I major histocompatibility heavy and light chains induced by viral peptides
32. Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes
33. Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors
34. Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas
35. Interferon-gamma treatment of B16 melanoma cells: Opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread